• Exchange: NASDAQ GS
  • Sector: Health Care
  • Industry: Medical Equipment & Devices
  • Sub-Industry: Life Science Equipment

Myriad Genetics Inc

+ Add to Watchlist


32.0100 USD 0.1500 0.47%

As of 16:30:00 ET on 11/20/2014.

Snapshot for Myriad Genetics Inc (MYGN)

Open: 31.8600 Day's Range: 31.8300 - 32.7500 Volume: 725,253
Previous Close: 32.1600 52wk Range: 20.0200 - 42.5000 1-Yr Rtn: +12.91%

Stock Chart for MYGN

No chart data available.
  • MYGN:US 32.0100
  • 1D
  • 1M
  • 1Y
Interactive MYGN Chart

Previous Close

No chart data available.
Interactive Chart
  • 1D
  • 1W
  • 1M
  • YTD
  • 1Y
  • 3Y
  • 5Y
Recently Viewed Symbols
Save as Watchlist
Saving as watchlist...

Key Statistics for MYGN

Current P/E Ratio (ttm) 17.6983
Estimated P/E(06/2015) 17.5516
Relative P/E vs. SPX 0.9658
Earnings Per Share (USD) (ttm) 1.8267
Est. EPS (USD) (06/2015) 1.8420
Est. PEG Ratio 1.1469
Market Cap (M USD) 2,359.62
Shares Outstanding (M) 72.99
30 Day Average Volume 840,613
Price/Book (mrq) 3.2806
Price/Sale (ttm) 3.1838
Dividend Indicated Gross Yield -%
Cash Dividend -
Dividend Ex-Date
5 Year Dividend Growth -
Next Earnings Announcement 02/04/2015
mrq = Most Recent Quarter; ttm = Trailing Twelve Months

Income Statement for MYGN

  • Revenue
  • Net Income (M/USD)
  • Profit Margin (%)

Company Profile & Key Executives for MYGN

Myriad Genetics, Inc. develops and markets molecular diagnostic products to provide physicians with information to help guide the care of their patients, to prevent disease, delay the onset of disease, or catch disease at an early stage.

Peter D MeldrumPresident/CEO/Co-FounderRobert Gardner HarrisonChief Information Officer
R Bryan RiggsbeeExec VP/CFO/TreasurerJerry S LanchburyChief Scientific Officer
More Company Profile & Key Executives for MYGN

Quotes delayed, except where indicated otherwise. All prices in local currency. Time is ET.

Sponsored Link
Sponsored Links
sec ||= nil